274 related articles for article (PubMed ID: 38585450)
1. Erythrocytes Nanoparticle Delivery: A Boon for Targeting Tumor.
Siddique AR; Bhagwat GS
Adv Pharm Bull; 2024 Mar; 14(1):132-146. PubMed ID: 38585450
[TBL] [Abstract][Full Text] [Related]
2. Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments.
Castro F; Martins C; Silveira MJ; Moura RP; Pereira CL; Sarmento B
Adv Drug Deliv Rev; 2021 Mar; 170():312-339. PubMed ID: 32946921
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.
Xia Q; Zhang Y; Li Z; Hou X; Feng N
Acta Pharm Sin B; 2019 Jul; 9(4):675-689. PubMed ID: 31384529
[TBL] [Abstract][Full Text] [Related]
4. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
[TBL] [Abstract][Full Text] [Related]
6. Recent advance of erythrocyte-mimicking nanovehicles: From bench to bedside.
Yang J; Wang F; Lu Y; Qi J; Deng L; Sousa F; Sarmento B; Xu X; Cui W
J Control Release; 2019 Nov; 314():81-91. PubMed ID: 31644936
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer.
Rezaei S; de Araújo Júnior RF; da Silva ILG; Schomann T; Eich C; Cruz LJ
Biomater Adv; 2023 Aug; 151():213456. PubMed ID: 37196459
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization.
Dehaini D; Wei X; Fang RH; Masson S; Angsantikul P; Luk BT; Zhang Y; Ying M; Jiang Y; Kroll AV; Gao W; Zhang L
Adv Mater; 2017 Apr; 29(16):. PubMed ID: 28199033
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.
Wang D; Dong H; Li M; Cao Y; Yang F; Zhang K; Dai W; Wang C; Zhang X
ACS Nano; 2018 Jun; 12(6):5241-5252. PubMed ID: 29800517
[TBL] [Abstract][Full Text] [Related]
10. Stem cell membrane-coated abiotic nanomaterials for biomedical applications.
Ferreira-Faria I; Yousefiasl S; Macário-Soares A; Pereira-Silva M; Peixoto D; Zafar H; Raza F; Faneca H; Veiga F; Hamblin MR; Tay FR; Gao J; Sharifi E; Makvandi P; Paiva-Santos AC
J Control Release; 2022 Nov; 351():174-197. PubMed ID: 36103910
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.
Song M; Dong S; An X; Zhang W; Shen N; Li Y; Guo C; Liu C; Li X; Chen S
J Control Release; 2022 May; 345():744-754. PubMed ID: 35381274
[TBL] [Abstract][Full Text] [Related]
12. Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy.
Dhas N; García MC; Kudarha R; Pandey A; Nikam AN; Gopalan D; Fernandes G; Soman S; Kulkarni S; Seetharam RN; Tiwari R; Wairkar S; Pardeshi C; Mutalik S
J Control Release; 2022 Jun; 346():71-97. PubMed ID: 35439581
[TBL] [Abstract][Full Text] [Related]
13. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice.
Gao C; Wang Y; Sun J; Han Y; Gong W; Li Y; Feng Y; Wang H; Yang M; Li Z; Yang Y; Gao C
Acta Biomater; 2020 May; 108():285-299. PubMed ID: 32251785
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cell delivery and cell membrane camouflaged PLGA nanoparticles in the delivery of shikonin for colorectal cancer treatment.
Zhou J; Jiang Z; Sun R; Pan D; Du Q; Zhou X; Chen Y; Chen Y; Peng J
Colloids Surf B Biointerfaces; 2024 Jun; 241():114017. PubMed ID: 38865869
[TBL] [Abstract][Full Text] [Related]
15. Enhanced photothermal therapy of biomimetic polypyrrole nanoparticles through improving blood flow perfusion.
Wang X; Li H; Liu X; Tian Y; Guo H; Jiang T; Luo Z; Jin K; Kuai X; Liu Y; Pang Z; Yang W; Shen S
Biomaterials; 2017 Oct; 143():130-141. PubMed ID: 28800434
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics.
Wang S; Wang Y; Jin K; Zhang B; Peng S; Nayak AK; Pang Z
Expert Opin Drug Deliv; 2022 Aug; 19(8):965-984. PubMed ID: 35917435
[TBL] [Abstract][Full Text] [Related]
17. Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivo.
Wang YQ; Huang C; Ye PJ; Long JR; Xu CH; Liu Y; Ling XL; Lv SY; He DX; Wei H; Yu CY
J Control Release; 2022 Jul; 347():400-413. PubMed ID: 35577150
[TBL] [Abstract][Full Text] [Related]
18. Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy.
Ye S; Wang F; Fan Z; Zhu Q; Tian H; Zhang Y; Jiang B; Hou Z; Li Y; Su G
ACS Appl Mater Interfaces; 2019 May; 11(17):15262-15275. PubMed ID: 30964624
[TBL] [Abstract][Full Text] [Related]
19. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment.
Li R; He Y; Zhang S; Qin J; Wang J
Acta Pharm Sin B; 2018 Jan; 8(1):14-22. PubMed ID: 29872619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
